A large-scale study of a computer-aided detection program for virtual colonoscopy showed solid performance, with almost 90% sensitivity for polyps 10 mm and larger, according to a presentation given at the sixth annual International Virtual Colonoscopy Symposium in Boston.
A large-scale study of a computer-aided detection program for virtual colonoscopy showed solid performance, with almost 90% sensitivity for polyps 10 mm and larger, according to a presentation given at the sixth annual International Virtual Colonoscopy Symposium in Boston.
Although still in its infancy, CAD for virtual colonoscopy garnered widespread attention at the symposium, including a slew of performance studies that will be presented at this year's RSNA meeting.
In research from one of the larger trials that will be presented at the RSNA meeting, Dr Ronald Summers, chief of clinical image processing service and virtual endoscopy and computer-aided diagnosis at the National Institutes of Health, and colleagues used a CAD system on data from the Department of Defense multicenter virtual colonoscopy trial. The data set included 1186 patients from three medical centers. There were two cancers and 178 adenomas 6 mm and larger.
Sensitivity per polyp achieved by the CAD system increased with an increase in polyp size:
False positives per patient declined with increasing polyp size:
Both cancers were detected with a rate of 0.7 false positives per patient, according to Summers.
The study examined a true screening population and used segmentally unblinded optical colonoscopy as a gold standard, said Dr. Jorge Soto, an associate professor of radiology at the Boston University School of Medicine.
"It is clear from this new data that CAD works," Soto said.
The optimism was tempered by caution. Soto, noting that larger studies of CAD were still needed, cautioned that a good CAD system added to a good radiologist doesn't automatically equal a better radiologist. Given the large numbers of false positives introduced by CAD systems, radiologists may be less likely to carefully scrutinize CAD marks, he said.
Still, both speakers advised keeping an eye out for a number of CAD studies that will be presented at the upcoming RSNA meeting.
"CAD is not only near, it is here," Summers said.
For more information from the online Diagnostic Imaging archives:
CAD holds key to screening virtual colonoscopy's future
Electronic subtraction fools CAD, leads to false positives
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.